2020 IDWeek*

Join me on a review of 5 impactful studies on the use of long-acting cabotegravir plus rilpivirine presented at the IDWeek 2020 virtual conference and how I believe these data will impact clinical practice.

Babafemi Taiwo, MBBS Released: November 23, 2020

Learn about new data presented at the IDWeek 2020 virtual conference on the use of bictegravir/emtricitabine/tenofovir alafenamide in individuals with HIV and end-stage renal disease on hemodialysis.

Eric S. Daar, MD Released: December 11, 2020